139 related articles for article (PubMed ID: 33231077)
1. A Y(III)-based Metal-Organic Framework as a Carrier in Chemodynamic Therapy.
Huang XJ; Yu SJ; Wang Y; Jin XK; Wang B; Gao LH; Zhu HL; Lin WX; Chen JJ
Inorg Chem; 2020 Dec; 59(23):17276-17281. PubMed ID: 33231077
[TBL] [Abstract][Full Text] [Related]
2. Doxorubicin-loaded nanoscale metal-organic framework for tumor-targeting combined chemotherapy and chemodynamic therapy.
Xue T; Xu C; Wang Y; Wang Y; Tian H; Zhang Y
Biomater Sci; 2019 Nov; 7(11):4615-4623. PubMed ID: 31441464
[TBL] [Abstract][Full Text] [Related]
3. Heparin-Coated Photosensitive Metal-Organic Frameworks as Drug Delivery Nanoplatforms of Autophagy Inhibitors for Sensitized Photodynamic Therapy against Breast Cancer.
Sun Q; Hou X; Yang J; Zhang M; Yang Y; Liu Y; Shen W; Yin D
ACS Appl Mater Interfaces; 2021 Nov; 13(46):55577-55590. PubMed ID: 34762394
[TBL] [Abstract][Full Text] [Related]
4. Programmed Release of Dihydroartemisinin for Synergistic Cancer Therapy Using a CaCO
Wan X; Zhong H; Pan W; Li Y; Chen Y; Li N; Tang B
Angew Chem Int Ed Engl; 2019 Oct; 58(40):14134-14139. PubMed ID: 31389105
[TBL] [Abstract][Full Text] [Related]
5. Chitosan Immobilization on Bio-MOF Nanostructures: A Biocompatible pH-Responsive Nanocarrier for Doxorubicin Release on MCF-7 Cell Lines of Human Breast Cancer.
Abazari R; Mahjoub AR; Ataei F; Morsali A; Carpenter-Warren CL; Mehdizadeh K; Slawin AMZ
Inorg Chem; 2018 Nov; 57(21):13364-13379. PubMed ID: 30351060
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of porphyrin-incorporating covalent organic frameworks for sonodynamic therapy.
Liu S; Zhou Y; Hu C; Cai L; Liu Z; Pang M
Chem Commun (Camb); 2021 Aug; 57(66):8178-8181. PubMed ID: 34318809
[TBL] [Abstract][Full Text] [Related]
7. Bimetallic metal-organic frameworks for tumor inhibition
Li A; Wang N; Song Y; Sun H; Cui J; Zhang G; Yu Q
Chem Commun (Camb); 2022 Feb; 58(14):2315-2318. PubMed ID: 35076033
[TBL] [Abstract][Full Text] [Related]
8. A Luminescent Amine-Functionalized Metal-Organic Framework Conjugated with Folic Acid as a Targeted Biocompatible pH-Responsive Nanocarrier for Apoptosis Induction in Breast Cancer Cells.
Abazari R; Ataei F; Morsali A; Slawin AMZ; L Carpenter-Warren C
ACS Appl Mater Interfaces; 2019 Dec; 11(49):45442-45454. PubMed ID: 31718155
[TBL] [Abstract][Full Text] [Related]
9. Silencing of Pyruvate Kinase M2
Huang S; Zhu W; Zhang F; Chen G; Kou X; Yang X; Ouyang G; Shen J
ACS Appl Mater Interfaces; 2021 Dec; 13(48):56972-56987. PubMed ID: 34797638
[TBL] [Abstract][Full Text] [Related]
10. Triple-Layered Metal-Organic Framework Hybrid for Tandem Response-Driven Enhanced Chemotherapy.
Wang F; Huang J; Xin H; Lei J
Chem Asian J; 2021 Aug; 16(15):2068-2074. PubMed ID: 34114330
[TBL] [Abstract][Full Text] [Related]
11. A biocompatible metal-organic framework as a pH and temperature dual-responsive drug carrier.
Lin W; Cui Y; Yang Y; Hu Q; Qian G
Dalton Trans; 2018 Nov; 47(44):15882-15887. PubMed ID: 30362496
[TBL] [Abstract][Full Text] [Related]
12. Preparation of a one-dimensional nanorod/metal organic framework Janus nanoplatform via side-specific growth for synergistic cancer therapy.
Zhang H; Zhang Q; Liu C; Han B
Biomater Sci; 2019 Mar; 7(4):1696-1704. PubMed ID: 30747179
[TBL] [Abstract][Full Text] [Related]
13. A small-sized and stable 2D metal-organic framework: a functional nanoplatform for effective photodynamic therapy.
Gao Z; Chen F; Li Y; Zhang Y; Cheng K; An P; Sun B
Dalton Trans; 2019 Dec; 48(45):16861-16868. PubMed ID: 31710076
[TBL] [Abstract][Full Text] [Related]
14. Facile Synthesis of a Cubic Porphyrin-Based Covalent Organic Framework for Combined Breast Cancer Therapy.
Liu S; Liu Z; Meng Q; Chen C; Pang M
ACS Appl Mater Interfaces; 2021 Dec; 13(48):56873-56880. PubMed ID: 34797623
[TBL] [Abstract][Full Text] [Related]
15. Missing-Linker-Assisted Artesunate Delivery by Metal-Organic Frameworks for Synergistic Cancer Treatment.
Wang D; He IW; Liu J; Jana D; Wu Y; Zhang X; Qian C; Guo Y; Chen X; Bindra AK; Zhao Y
Angew Chem Int Ed Engl; 2021 Dec; 60(50):26254-26259. PubMed ID: 34591365
[TBL] [Abstract][Full Text] [Related]
16. Covalent Organic Framework-Based Nanocomposite for Synergetic Photo-, Chemodynamic-, and Immunotherapies.
Liu S; Zhou Y; Hu C; Cai L; Pang M
ACS Appl Mater Interfaces; 2020 Sep; 12(39):43456-43465. PubMed ID: 32880166
[TBL] [Abstract][Full Text] [Related]
17. A biomimetic MOF nanoreactor enables synergistic suppression of intracellular defense systems for augmented tumor ablation.
Gao P; Shi M; Wei R; Pan W; Liu X; Li N; Tang B
Chem Commun (Camb); 2020 Jan; 56(6):924-927. PubMed ID: 31850458
[TBL] [Abstract][Full Text] [Related]
18. Enhancing anticancer cytotoxicity through bimodal drug delivery from ultrasmall Zr MOF nanoparticles.
Abánades Lázaro I; Abánades Lázaro S; Forgan RS
Chem Commun (Camb); 2018 Mar; 54(22):2792-2795. PubMed ID: 29485148
[TBL] [Abstract][Full Text] [Related]
19. A natural polysaccharide mediated MOF-based Ce6 delivery system with improved biological properties for photodynamic therapy.
Fu X; Yang Z; Deng T; Chen J; Wen Y; Fu X; Zhou L; Zhu Z; Yu C
J Mater Chem B; 2020 Feb; 8(7):1481-1488. PubMed ID: 31996879
[TBL] [Abstract][Full Text] [Related]
20. Nanoscale Covalent Organic Framework for Combinatorial Antitumor Photodynamic and Photothermal Therapy.
Guan Q; Zhou LL; Li YA; Li WY; Wang S; Song C; Dong YB
ACS Nano; 2019 Nov; 13(11):13304-13316. PubMed ID: 31689082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
